Intrinsiqs

Is Madrigal Pharmaceuticals, Inc. overvalued?

Madrigal Pharmaceuticals, Inc. (MDGL) — key valuation metrics and fundamentals.

No verdict
Price
$510.66
Fair value
Current P/E
Normal P/E
Market cap
$11.96B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares MDGL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.